β2-agonist clenbuterol induced changes in the distribution of white blood cells in rats

Journal of Pharmacological Sciences

Volumn 104, Issue 2, 2007, Pages 146-152

  Shirato, Ken ^a   Tanihata, Jun ^a   Motohashi, Norio ^a   Tachiyashiki, Kaoru ^b   Tomoda, Akio ^c   Imaizumi, Kazuhiko ^a  

^a WASEDA UNIVERSITY   (Japan)

^b JOETSU UNIVERSITY OF EDUCATION   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Clenbuterol; Immune responsive system; Lymphocyte; White blood cell; 2 agonist

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; HEMOGLOBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BASOPHIL; CELL COUNT; CELLULAR DISTRIBUTION; CIRCULATION; CONTROLLED STUDY; DRUG RESPONSE; EOSINOPHIL COUNT; IMMUNE RESPONSE; LEUKOCYTE; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MONOCYTE; NEUTROPHIL COUNT; NONHUMAN; RAT; ANIMAL; BODY WEIGHT; DRUG EFFECT; ERYTHROCYTE; METABOLISM; ORGAN SIZE; SPRAGUE DAWLEY RAT;

ADRENERGIC BETA-AGONISTS; ANIMALS; BODY WEIGHT; CLENBUTEROL; ERYTHROCYTES; HEMOGLOBINS; LEUKOCYTE COUNT; LEUKOCYTES; MALE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34250804721     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0070267     Document Type: Article

References (42)

1. Clarkson PM, Thompson HS. Drugs and sport: research finding and limitations. Sports Med. 1997;24:366-384.
2. Dekhuijzen PNR, Machiels HA, Heunks MA, van der Heiden HFM, van Balkom RHH. Athletes and doping: effects of drug on the respiratory system. Thorax. 1999;54:1041-1046.
3. Babij P, Booth FW. Clenbuterol prevents or inhibits loss of specific mRNAs in atrophying rat skeletal muscle. Am J Physiol. 1988;254:C656-C660.
4. Bremner P, Woodman K, Burgess C, Crane J, Purdie G, Pearce N, et al. A comparison of the cardiovascular and metabolic effects of formoterol, salbutamol and fenoterol. Eur Respir J. 1993;6:204-210.
5. 2-adrenergic agonists on body composition and protein synthesis in the rat. Biosci Rep. 1984;4:83-91.
6. Prather ID, Brown DE, North P, Wilson JR. Clenbuterol: a suitable for anabolic steroids? Med Sci Sports Exerc. 1995;27:1118-1121.
7. 2- adrenoceptors in lung and skeletal muscle. J Anim Sci. 2000;78:604-608.
8. Hunt DG, Ding Z, Iry J. Clenbuterol prevents epinephrine from antagonizing insulin-stimulated muscle glucose uptake. J Appl Physiol. 2002;92:1285-1292.
9. 2-agonist, clenbuterol-induced changes of skeletal muscle mass in rats. Jpn J Physiol. 2002;52 Suppl:S215.
10. Reed P, Hay SM, Dorwood PM, Palmer RM. Stimulation of muscle growth by clenbuterol: lack of effect on muscle protein biosynthesis. Br J Nutr. 1986;56:249-258.
11. 2-Agonist administration reverses muscle wasting and improves muscle function in aged rats. J Physiol. 2003;551:175-188.
12. 2-adrenergic agonists on rainbow trout muscle proteases and proteins. Comp Biochem Physiol. 2006;A144:145-154.
13. Philipson LH. β-Agonist and metabolism. J Allergy Clin Immunol. 2002;110:S313-S317.
14. + T and B lymphocyte function in vitro and in vivo. Pharmacol Rev. 2001;53:487-525.
15. Barnes PJ. Effect of beta-agonists on inflammatory cells. J Allergy Clin Immunol. 1999;104 Suppl:S10-S17.
16. Elferink JG, VanUffelen BE. The role of cyclic nucleotides in neutrophil migration. Gen Pharmacol. 1996;27:387-393.
17. Straub RH, Mayer M, Kreutz M, Leeb S, Scholmerich J, Falk W. Neurotransmitters of the sympathetic nerve terminal are powerful chemoattractants for monocytes. J Leukoc Biol. 2000; 67:553-558.
18. 2-receptor agonist, attenuates lipopolysaccharide- induced lung inflammation in mice. Am J Physiol Lung Cell Mol Physiol. 2004;286:L1122-L1128.
19. Harada S, Tachiyashiki K, Imaizumi K. Effects of sex hormones on rat liver cytosolic alcohol dehydrogenase activity. J Nutr Sci Vitaminol. 1998;44:625-639.
20. 18-unsaturated fatty acids on plasma ethanol levels and gastric emptying in ethanol-administered rats. J Nutr Sci Vitaminol. 1993;39:163-176.
21. 2- Agonist, clenbuterol-induced changes of plasma energy substrate levels, and extracellular fluid volume in rats. Jpn J Physiol. 2002;52 Suppl:S214.
22. Shirato K, Motohashi N, Tanihata J, Tachiyashiki K, Tomoda A, Imaizumi K. Effects of two types of inactivity on the number of white blood cells in rats. Eur J Appl Physiol. 2006;98:590-600.
23. Shiga T, Imaizumi K, Harada N, Sekiya M. Kinetics of rouleax formation using TV image analyzer. I. human erythrocytes. Am J Physiol. 1983;245 (Heart Circ Physiol 14):H252-H258.
24. 2 agonist clenbuterol. Vet Immunol Immunopathol. 2003;96:111-115.
25. McConkey DJ, Orrenius S, Jondal M. Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. J Immunol. 1990; 145:1227-1230.
26. Illera JC, Silván G, Blass A, Martínez MM, Illera M. The effect of clenbuterol on adrenal function in rats. Analyst. 1998;123: 2521-2524.
27. Tarcic N, Ovadia H, Weiss DW, Weidenfeld J. Restraint stress-induced thymic involution and cell apoptosis are dependent on endogenous glucocorticoids. J Neuroimmunol. 1998;82:40-46.
28. 2-agonist clenbuterol help to maintain myocardial potential to recover during mechanical unloading? Circulation. 2005;112:51-56.
29. Witte K, Kinzler N, Schnecko A, Oldrich HG, Lemmer B. Effects of β-adrenoceptor blockade on β-adrenergic signal transduction in cardiomyopathic hamster (BIO 8262) hearts. Eur J Pharmacol. 1997;334:209-216.
30. Nieman DC, Berk LS, Simpson-Westerberg M, Arabatzis K, Youngberg S, Tan SA, et al. Effects of long-endurance running on immune system parameters and lymphocyte function in experienced marathoners. Int J Sports Med. 1989;10:317-323.
31. Suzuki K, Nakaji S, Yamada M, Liu Q, Kurakake S, Okamura N, et al. Impact of a competitive marathon race on systemic cytokine and neutrophil responses. Med Sci Sports Exerc. 2003;35:348-355.
32. Bishop CR, Athens JW, Boggs DR, Warner HR, Cartwright GE, Wintrobe MM. Leukokinetic studies, 13: a non-steady-state kinetic evaluation of the mechanism of cortisone-induced granulocytosis. J Clin Invest. 1968;47:249-260.
33. Suda T, Yamaguchi Y, Suda J, Miura J, Okano A, Akiyama Y. Effect of interleukin 6 (IL-6) on the differentiation and proliferation of murine and human hemopoietic progenitors. Exp Hematol. 1988;16:891-895.
34. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. J Immunol. 1995;154:4719-4725.
35. Dale DC, Fauci AS, Wolff SM. Alternative-day prednisone: leukocyte kinetics and susceptibility to infections. N Engl J Med. 1974;291:1154-1158.
36. Burgess AW, Metcalf D. The nature and action of granulocyte-macrophage colony stimulating factors. Blood. 1980;56:947-958.
37. Metcalf D, Nicola NA. Proliferative effects of purified granulocyte colony-stimulating factor (G-CSF) on normal mouse hemopoietic cells. J Cell Physiol. 1983;116:198-206.
38. van Furth R, Sluiter W. Distribution of blood monocytes between a marginating and a circulating pool. J Exp Med. 1986;163:474-479.
39. Suzuki K, Sato H, Kikuchi T, Abe T, Nakaji S, Sugawara K, et al. Capacity of circulating neutrophils to produce reactive oxygen species after exhaustive exercise. J Appl Physiol. 1996;81:1213-1222.
40. van Furth R, Cohn ZA. The origin and kinetics of mononuclear phagocytes. J Exp Med. 1968;128:415-435.
41. Cioca DP, Watanabe N, Isobe M. Apoptosis of peripheral blood lymphocyte is induced by catecholamines. Jpn Heart J. 2000;41:385-399.
42. Nittoh T, Fujimori H, Kozumi Y, Ishihara K, Mue S, Ohuchi K. Effects of glucocorticoids on apoptosis of infiltrated eosinophils and neutrophils in rats. Eur J Pharmacol. 1998;351:73-81.